Companies: 10,795·Total market cap: $144.5T
Healios K.K.

Healios K.K.

HLOSFOTCHealthcare● Active
$2.70
+$0.90(+50.00%)
Market Cap$290683229
P/E Ratio
52W High$4.45
52W Low$1.8
Overview

Healios K.K.(HLOSF)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · HLOSF · 截至 Jun 9, 2026

关键指标

EPS (TTM)$-23.96hlosf eps ttm · hlosf earnings per shareEarnings history
PE Ratio (TTM)hlosf pe ratio ttm · hlosf price to earningsPE Ratio deep dive
Revenue (TTM)$74.3Mhlosf revenue ttm · hlosf annual revenueFull revenue history
Dividend Yield不分红does hlosf pay dividends · hlosf dividend yieldDividend history
Shares Outstanding107.7Mhlosf shares outstanding · hlosf floatShares outstanding history
Next EarningsAug 18, 2026Est.hlosf earnings date · hlosf next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$104.1M▼ 81.41% YoY
202320242025
healios k.k. revenue · hlosf revenue 2025
FY 2025Net Income-$2.22B▲ +47.60% YoY
202320242025
healios k.k. net income · hlosf profit 2025
FY 2025EPS$-20.39▲ +57.41% YoY
202320242025
hlosf eps · healios k.k. earnings per share 2025
TTM:Revenue: $74.3MNet Income: -$3.15BEPS: $-23.96View income statement →

分析师评级与目标价

完整预测
SellBuy
Buy2 位分析师is hlosf a buy · hlosf analyst rating
Strong Buy
0
Buy
2
Hold
0
Sell
0
Strong Sell
0
12-Month Price Target
$Low
$2.70Current
$Avg Target
$High
hlosf price target · hlosf 12 month forecast

合计: 2 · 买入占比: 100.0%

股票表现

完整历史
1D+50.00%
1W+50.00%
1M+22.73%
3M-1.82%
YTD+39.90%
1Y-14.83%
5Y-81.44%

关于 Healios K.K.

CEOTadahisa S. Kagimoto
IPO DateNov 9, 2020
Employees65
CountryJP

Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, …

what is healios k.k. · hlosf stock overview · healios k.k. company profile · who is healios k.k. ceo · hlosf OTC · healios k.k. headquarters · healios k.k. business segments

关于股票概览与关键数据

Healios K.K.(HLOSF)是 Biotechnology 行业的 Healthcare 类公司,于 Nov 9, 2020 在 OTC 上市。截至最近交易日,HLOSF 股价为 $2.70,市值约为 $290.7M。过去12个月累计回报 -14.83%,年初至今回报 +39.90%。

根据 2 位华尔街分析师,Healios K.K. 股票共识评级为Buy,12个月平均目标价为 $—。2025 财年 Healios K.K. 营收 $104.1M,净利润 -$2.2B。更多数据(营收历史、盈利、股息、市盈率)请使用上方标签页。

常见问题

截至最近一个交易日,Healios K.K.(HLOSF)股价为 $2.70,在 OTC 上市,52周区间为 $1.80 – $4.45。

HLOSF 最新股价HLOSF quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议